YU39594A - Materije i postupci za odabiranje sredstava protiv osteoporoze - Google Patents
Materije i postupci za odabiranje sredstava protiv osteoporozeInfo
- Publication number
- YU39594A YU39594A YU39594A YU39594A YU39594A YU 39594 A YU39594 A YU 39594A YU 39594 A YU39594 A YU 39594A YU 39594 A YU39594 A YU 39594A YU 39594 A YU39594 A YU 39594A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- estrogen
- testing
- compound
- mammal
- induce transcription
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/495—Transforming growth factor [TGF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Opisane su materije za odabiranje jedinjenja koje može da pobudi transkripciju iz elementa osetljivog na raloksifen promotora kod sisara, koje nije nespecifični pobudilac transkripcije, ne može da pobudi transkripciju iz elementa osetljivog na estrogen promotora kod sisara i koje je antiestrogensko ili neestirogensko jedinjenje. Takođe je opisan postupak za odabiranje ovih jedinjenja koji obuhvata faze: ispitivanje na sposobnost jedinjenja da pobudi transkripciju iz elementa osetljivog na raloksifen promotora kod sisara, ispitivanje na nemogućnost jedinjenja da pobudi transkripciju iz promotora kod sisara koji nema element osetljiv na raloksifen, ispitivanje na nemogućnost jedinjenja da pobudi transkripciju iz promotora osetljivog na estrogen, i ispitivanje na sposobnost jedinjenja da inhibira estrogensko pobudjivanje transkripcije iz promotora osetljivog na estrogen u prisustvu estrogena.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/081,610 US5445941A (en) | 1993-06-21 | 1993-06-21 | Method for screening anti-osteoporosis agents |
US24699094A | 1994-05-18 | 1994-05-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU39594A true YU39594A (sh) | 1997-03-07 |
Family
ID=26765750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU39594A YU39594A (sh) | 1993-06-21 | 1994-06-20 | Materije i postupci za odabiranje sredstava protiv osteoporoze |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0629697A3 (sh) |
JP (1) | JPH07184661A (sh) |
KR (1) | KR950000875A (sh) |
CN (1) | CN1102437A (sh) |
AU (2) | AU677319B2 (sh) |
BR (1) | BR9402480A (sh) |
CA (1) | CA2126294A1 (sh) |
CZ (1) | CZ147594A3 (sh) |
FI (1) | FI942958A (sh) |
HU (1) | HUT70326A (sh) |
IL (1) | IL109990A (sh) |
NO (1) | NO942313L (sh) |
PL (1) | PL177706B1 (sh) |
YU (1) | YU39594A (sh) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6395494B1 (en) | 1993-05-13 | 2002-05-28 | Neorx Corporation | Method to determine TGF-β |
US6251920B1 (en) | 1993-05-13 | 2001-06-26 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5723291A (en) * | 1993-09-01 | 1998-03-03 | The Regents Of The University Of California | Methods for screening compounds for estrogenic activity |
US6156723A (en) | 1993-09-01 | 2000-12-05 | The Regents Of The University Of California | Compositions comprising inhibitors of estrogen response |
US5552415A (en) * | 1993-12-21 | 1996-09-03 | Eli Lilly And Company | Method of inhibiting Alzheimer's Disease |
US6083690A (en) * | 1995-06-02 | 2000-07-04 | Osteoscreen, Inc. | Methods and compositions for identifying osteogenic agents |
JP3761628B2 (ja) * | 1995-07-14 | 2006-03-29 | 住友化学株式会社 | 植物プロモーターおよびその利用 |
AU5558498A (en) * | 1996-11-22 | 1998-06-22 | Akzo Nobel N.V. | Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis |
WO1998046588A2 (en) * | 1997-04-11 | 1998-10-22 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
EP0998936B1 (en) * | 1998-10-01 | 2006-03-15 | Giovanni Gambaro | Substances for the prevention of pathological overexpression of TGF-Beta and methods for evaluating same |
GB9822682D0 (en) * | 1998-10-16 | 1998-12-09 | Gemini Research Limited | Diagnostic method and apparatus based on polymorphism in a TGF-B-Gene |
GB9913649D0 (en) * | 1999-06-11 | 1999-08-11 | Karobio Ab | Estrogen receptor |
US7141661B2 (en) | 2000-09-08 | 2006-11-28 | The United States Of America As Represented By The Department Of Health And Human Services | Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties |
KR100504042B1 (ko) * | 2002-10-23 | 2005-08-01 | 신경주 | 자가 세차장치를 구비한 자동차 |
CN106841258A (zh) * | 2016-12-30 | 2017-06-13 | 遵义医学院附属医院 | 一种筛选用于促进骨愈合的药物的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU509682B2 (en) * | 1975-10-28 | 1980-05-22 | Eli Lilly And Company | 2-Aroyl-3-Phenylbenzothiophene Derivatives |
US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
US5071773A (en) * | 1986-10-24 | 1991-12-10 | The Salk Institute For Biological Studies | Hormone receptor-related bioassays |
US4935363A (en) * | 1987-03-30 | 1990-06-19 | Board Of Regents, The University Of Texas System | Sterol regulatory elements |
-
1994
- 1994-06-13 IL IL10999094A patent/IL109990A/xx not_active IP Right Cessation
- 1994-06-14 AU AU64701/94A patent/AU677319B2/en not_active Withdrawn - After Issue
- 1994-06-15 CZ CZ941475A patent/CZ147594A3/cs unknown
- 1994-06-17 NO NO942313A patent/NO942313L/no unknown
- 1994-06-20 YU YU39594A patent/YU39594A/sh unknown
- 1994-06-20 KR KR1019940013849A patent/KR950000875A/ko not_active Application Discontinuation
- 1994-06-20 CA CA002126294A patent/CA2126294A1/en not_active Abandoned
- 1994-06-20 FI FI942958A patent/FI942958A/fi unknown
- 1994-06-20 PL PL94303915A patent/PL177706B1/pl unknown
- 1994-06-20 JP JP6137287A patent/JPH07184661A/ja not_active Withdrawn
- 1994-06-20 EP EP94304432A patent/EP0629697A3/en not_active Withdrawn
- 1994-06-20 CN CN94106717A patent/CN1102437A/zh active Pending
- 1994-06-20 HU HU9401851A patent/HUT70326A/hu unknown
- 1994-06-20 BR BR9402480A patent/BR9402480A/pt not_active Application Discontinuation
-
1997
- 1997-07-17 AU AU28710/97A patent/AU2871097A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU677319B2 (en) | 1997-04-17 |
CN1102437A (zh) | 1995-05-10 |
EP0629697A3 (en) | 1995-04-19 |
IL109990A0 (en) | 1994-10-07 |
JPH07184661A (ja) | 1995-07-25 |
CZ147594A3 (en) | 1995-06-14 |
HUT70326A (en) | 1995-09-28 |
PL303915A1 (en) | 1995-01-09 |
NO942313D0 (no) | 1994-06-17 |
HU9401851D0 (en) | 1994-09-28 |
NO942313L (no) | 1994-12-22 |
AU6470194A (en) | 1994-12-22 |
PL177706B1 (pl) | 2000-01-31 |
FI942958A0 (fi) | 1994-06-20 |
CA2126294A1 (en) | 1994-12-22 |
KR950000875A (ko) | 1995-01-03 |
IL109990A (en) | 1999-06-20 |
AU2871097A (en) | 1997-09-25 |
EP0629697A2 (en) | 1994-12-21 |
BR9402480A (pt) | 1995-01-25 |
FI942958A (fi) | 1994-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU39594A (sh) | Materije i postupci za odabiranje sredstava protiv osteoporoze | |
MX9200324A (es) | Nuevos esteroides, procedimiento para su preparacinuevos esteroides, procedimiento para su preparacion y composicion farmaceutica que los contiene. on y composicion farmaceutica que los contiene. | |
ES2145327T3 (es) | Uso de marcadores fluorescentes para productos petroliferos. | |
AR007343A1 (es) | Metodo para expender articulos absorbentes de tipos diferentes | |
BR9800672A (pt) | Método e aparelho para completar um poço subterrâneo | |
DE69831721D1 (de) | Verfahren zum untersuchen einer ungleichmässigkeit eines transparenten materials | |
WO2000057298A3 (en) | Apparatus and method for providing a business card web page | |
DE69529126T2 (de) | Verfahren zum Prüfem von Formationen niedriger Durchlässigkeit | |
DE19983066T1 (de) | Ausführung von Befehlen an gepackten Daten partieller Breite | |
BR9814714B1 (pt) | processo para o controle de que o grupo de cigarros esteja com a quantidade completa e do enchimento dos cigarros. | |
ES2137549T3 (es) | Derivados antifungicos de sordaridina. | |
BR9201591A (pt) | Reagente de sonda,metodo para a construcao de um reagente e kit | |
MX9200731A (es) | Compuestos de hidrazona, procedimientos para su prcompuestos de hidrazona, procedimientos para su preparacion, compuestos intermedios utiles para su oeparacion, compuestos intermedios utiles para suobtencion y composiciones pesticidas que contienena btencion y composiciones pesticidas que contienenalos mismos. los mismos. | |
DE69208108T3 (de) | Verfahren zur Prüfung von Gasleckage | |
NO305218B1 (no) | FremgangsmÕte for lokalisering av hydrokarbonreservoarer | |
BR9608686A (pt) | Método para a detecção de compostos que modulam os efeitos da obesoproteína | |
MX9204237A (es) | Nuevos derivados de ciclohexano y tetrahidropiran, procedimiento para su preparacion y composicion antifungal que los contiene. | |
BR8007851A (pt) | Metodo para desodorizar e remover produtos quimicos organicos | |
DE69835220D1 (de) | Zusammensetzungen für streckbarer umhüllungsfilm, der hafteigenschaften zeigt | |
FI943500A0 (fi) | Menetelmä ja laite kartonkisydämen päiden leviämislujuuden testaamiseksi | |
PA8454301A1 (es) | Composiciones solubilizadas de sertralina | |
ES2073731T3 (es) | Medio para aplicacion transdermica que contiene rolipram. | |
FI946189A0 (fi) | 5-alfa-reduktaasi-inhibiittoreina käyttökelpoiset 17-alkyyliketonisteroidit | |
MX9203867A (es) | Fibridos que contienen carbon activado y metodo para su fabricacion. | |
NL191867C (nl) | Bekrachtigingsspoel voor electrodeloze HID-lampen. |